CK Science Salary Survey 2013

Your chance to complete the 2013 CK Science Salary Survey is almost over.

Science jobsThe science salary survey will be closing at the end of February so this is the last chance you will have to  take part. It takes only 5 minutes to complete, and your participation will help us understand what the 2012 science salary brackets were. The results of this survey will be published and will help you with your job and salary expectations for 2013.

Click on the link below to complete the CK Science Salary Survey

https://www.surveymonkey.com/s/cksciencesalarysurvey

 Are you are currently looking for a job within the Science industry?

Click here to view all our science jobs

Science jobs uk   Science jobs UK

 

Posted in NewsTagged in , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

New Science park creates over 2000 jobs

ThA new-state-of-the-art Science park will bring 2,000 jobs to Wiltshiree Swindon Advertiser has reported that a new state-of-the-art science park will be developed at Porton in Wiltshire creating more than 2,000 jobs over a 10-year-period and bringing national and international investment into the area.

Wiltshire Council and a joint development company, comprising Trebor Developments LLP and Wrenbridge Land Limited, will develop the science park. The successfully bided  for £10m funding from the Department of Business, Innovation and Skills (BIS). This will help kick-start the first phase of the science park project, creating the infrastructure for the planned 355,000 sq ft science park and a new 23,000 sq ft innovation centre

This new science park will  provide facilities for science- and research-based industries and could attract £70m of private sector investment over the next 10 years.

 

Are you looking for a new science based role?

Click here to see our latest science jobs

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

GSK invest 10 million euros at their facility in Sligo, Ireland

Pharmatimes have reported that GlaxoSmithKline has decided to keep open its facility in Sligo Ireland and will instead invest 10 million euros into the plant.

GSK acquired the facility in Sligo when GSK bought the dermatology specialist Stiefel Laboratories for up to $3.6 billion in 2009.

There will be some jobs cuts at the plant over the next two years, which currently employs 180 people, with a “gradual” reduction to 120. However, GlaxoSmthKline estimated there would be an additional 50 jobs added in 2014 as the plant improved skills and capacity.

 

If you are looking for a new job in science why not look at our current science based vacancies?

Click here to see our latest jobs in the science industry

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , , , , , ,

UK stem cell pioneer shares Nobel Prize in Medicine

The BBC has reported that two pioneers of stem cell research have shared the Nobel prize for medicine and/ or physiology

John Gurdon from the UK and Shinya Yamanaka from Japan have been jointly awarded the prize for their work in transforming specialised cells into stem cells, which can become any other type of cell in the body. It is hoped the techniques discovered will revolutionise medicine by using a sample of a person’s skin to create stem cells.

Prof Anthony Hollander, the head of cellular and molecular medicine at the University of Bristol, said: “This joint Nobel Prize traces and celebrates the wonderful scientific journey from John Gurdon’s pioneering early work to the sensational discovery of somatic cell reprogramming by Shinya Yamanaka. It’s fantastic news for stem cell research.”

The prize was awarded this morning at the Karolinska Institute in Sweden, and is the most coveted award in medical science. The Nobel committee said these winners  had “revolutionised” science

 

If you are looking for a new job in science why not look at our current science based vacancies?

Click here to see our latest jobs in the science industry

 

Posted in Industry News, Jobs, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , , ,

Allergans Botox receives UK approval for treatment of MS/spinal injury

CK Science - Scientific Recruitment AgencyPharmaTimes have reported that Allergan’s Botox is now licensed in the UK for patients who have continence issues because of multiple sclerosis or a spinal injury.

The Medicines and Healthcare products Regulatory Agency has give Allergan permission to use Botox (botulinum toxin type A) for managing urinary incontinence caused by neurogenic detrusor overactivity due to subcervical spinal cord injury or multiple sclerosis (MS),

Professor Christopher Chapple, Urology Department, Royal Hallamshire Hospital, Sheffield NHS Trust and a key investigator in the neurogenic detrusor overactivity registration trials, has welcomed the new license, noting that “being able to better control and manage bladder function can be life-changing for patients”.

 

If you are looking for a new job in science why not look at our current science based vacancies?

Click here to see our latest jobs in the science industry

Posted in Industry News, Jobs, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , , , , ,

UCB launches its new biotechnology facility

PharmaTimes has reported that UCB has launched its 65 million euro pilot biotechnology plant in Belgium.

The new facility is located at its Braine-l’Alleud site and will employ 100 employees. This new facility will produce cell culture-based therapeutic proteins that are dedicated to accelerating the availability of new drugs for severe diseases with a focus on the research and clinical trial phases

This new facility is designed enable UCB to improve its biological medicines.

Chief executive Roch Doliveux said that “today, 33% of drugs for human use worldwide are of biotechnological origin and represent more than half of UCB’s current R&D pipeline”. He added that “with this bio pilot plant, we will more rapidly initiate clinical studies of new antibody-based therapeutics”.

 

Are you looking for a new science based role?

Click here to see our latest science jobs

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , , , , ,

Novartis’s rare cancer drug is launched in the UK

Pharmatimes have reported that Novartis have launched their new drug Jakavi which means for the first time patients in the UK with a rare form of blood cancer will now have access to this targeted therapy

Jakavi (ruxolitinib) is a first-in-class JAK 1 and JAK 2 inhibitor, and is now available to treat patients in the UK with disease-related enlarged spleen or various forms of myelofibrosis, which affects around 0.34-0.76 people in every 100,000.

Myelofibrosis is a rare, potentially life-threatening blood cancer characterised by bone marrow failure, enlarged spleen and debilitating symptoms including extreme fatigue, poor quality of life and weight loss, and shortened survival.

Jakavi received EU approval at the end of August 2012

 

Are you looking for a new job in the pharmaceutical  industry?

Click here to see our latest pharmaceutical jobs?

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

£2.8 billion renewable energy investment in Scotland

Scottish Development International has reported that Scotland’s renewable energy industry has attracted £2.8 billion capital investment since 2009.

Onshore wind accounts for 57 percent of total investment with 21 percent going to offshore wind. The rest of the investment has been deivded between wave and tidal energy, solar photovoltaic, hydro energy, landfill gas and biofuels.

Niall Stuart, chief executive of Scottish Renewables said “These figures show Scotland’s renewables industry is very much bucking the economic trend.  During the downturn our industry has delivered some £2.8bn of much needed capital investment in our economy.  This has helped to grow the supply chain, secure the future of many companies and support more than 11,000 jobs”

 

Are you looking for a new science based role?

Click here to see our latest science jobs

Posted in Jobs, NewsTagged in , , , , , , , , , , , , , , , , , , , , ,

Grapefruit juice provides anti-cancer benefits

As reported by WorldPharmaNews, results of a clinical trial have showed that a glass a day of grapefruit juice lets patients derive the same benefits from an anti-cancer drug as they would get from more than three times as much of the drug by itself.

Researchers at the University of Chicago Medicine study the effects that foods can have on the uptake and elimination of drugs used for cancer treatment.

In the study, they found that eight ounces a day of grapefruit juice can slow the body’s metabolism of a drug called sirolimus, which has been approved for transplant patients but may also help many people with cancer.

Patients who drank eight ounces a day of grapefruit juice increased their sirolimus levels by 350 percent. A drug called ketoconazole that also slows drug metabolism increased sirolimus levels by 500 percent.

The hope is that this combination could help patients avoid side effects associated with high doses of the drug and reduce the cost of the medication.

 

Click here to see our latest pharmaceutical jobs

      

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Olympic Team GB work with scientists on gene tests for injuries

As reported by the BBC, Scientists behind Olympic Team GB are working on genetic tests to understand why some athletes are prone to injury Scientists at the Institute for Human Health and Performance at University College London are currently researching how and why tendon injuries and stress fractures occur as they are common in elite athletes University College London’s Prof Hugh Montgomery says they have found a gene they think strongly influences the risk of stress fracture…….If we understood that genetic component we would have a much better understanding of the patho-physiology – the disease processes that let that happen” The study has been working with the English Institute of Sport (EIS), which aims to apply the latest in sports science and medicine for the benefit of Britain’s Olympic and Paralympic athletes. EIS’s Director of Sport Science, Dr Ken van Someren said “If we can identify some particular genes that are associated with a higher risk of injury in certain individuals, and we think we’re close, we can tailor the training, conditioning and preparation that we put those individuals through.”

Are you looking for a new science based role?

Click here to see our latest science jobs

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , ,

GSK supports Olympics anti doping operation

The Guardian has reported that GSK today marks its role as Official Laboratory Services Provider for the London 2012 Olympic and Paralympic Games by launching its first UK advertising campaign to celebrate the role that anti-doping science will play in helping ensure this summer’s Games are the cleanest possible.

The multimillion-pound ad campaign features a string of British athletes, including Marlon Devonish and Phillips Idowu to highlight its role running the anti-doping testing laboratory for the London Olympic games.

The London 2012 anti-doping laboratory, provided by GSK in partnership with the London Organising Committee for the Olympic and Paralympic Games (LOCOG) and King’s College London opened today and will be operational 24 hours a day, seven days a week. More tests will be carried out at the London 2012 lab, based at GSK’s Harlow site, than at any other Games with every medallist and up to 50 per cent of all competing athletes being tested.

 

Click here to see our latest science jobs

Follow us on Twitter @CKScienceJobs to receive more industry news and CK jobs of the week updates

 

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , ,

MSD and the Bill & Melinda Gates Foundation announce collaboration to improve family planning

Pharmiweb have reported that MerckSharpeDohme  and the Bill & Melinda Gates Foundation today announced that they will work together to expand access to family planning, a critical step in improving the health of women around the world.

MSD intends to pledge up to $25 million over eight years as part of MSD/Merck for Mothers – the company’s 10-year initiative to reduce maternal mortality around the world. This pledge will be matched by the Gates Foundation as part of its commitment to family planning.

Kenneth C. Frazier, Merck’s chairman and CEO said in the press release that Merck is proud to work in collaboration with the Gates Foundation to help to ensure that many more women around the world have the information and services they need to make practical and informed choices about planning their families……….This important initiative will help us accelerate the work of Merck for Mothers in saving women’s lives.”

 

Are you looking for a new job in Science?

Click here to see our latest science jobs

Posted in General, NewsTagged in , , , , , , , , , , , , , , , , , , , ,

GSK & Theravance receive positive data for pill

PharmaTimes have reported that GlaxoSmithKline and Theravance have reported positive data from four Phase III trials assessing a combination therapy for maintenance treatment of COPD, making the once-daily pill closer to a regulatory filing.

The clinical trials involved more than 4,000 patients, including two 24-week efficacy trials comparing a combination of the long-acting muscarinic antagonist (LAMA) umeclidinium bromide and the long-acting beta-agonist (LABA) vilanterol. The date showed statistically significant improvements when compared with placebo and the individual parts in both trials, which tested difference doses.

Darrell Baker, SVP Respiratory Portfolio Optimisation Leader at GSK said “We are very encouraged by the results of these initial studies for our LAMA/LABA, an important cornerstone of our broad respiratory development portfolio…. These studies, together with our earlier dose-ranging work, give us confidence that this is a once-daily medicine with the potential to benefit many patients with COPD.

 

Click here to see our latest scientifc jobs

Follow us on Twitter @CKScienceJobs to receive more industry news and CK jobs of the week updates

Posted in NewsTagged in , , , , , , , , , , , , , , , , , , , , , ,

P&G help London clean up for the Olympics!

SuperSavyMe has reported that P&G has teamed up with the Mayor of London to bring the P&G Capital Clean Up campaign to help clean the capital before the London 2012 Olympic Games

The campaign started in March 2012 and over the last three months, Proctor and Gamble have hosted  a series of clean up events designed to bring Londoners together to spruce up neglected areas of the city as London gears up to host the Olympic games.

The events so far have involved clearing the region of 1,000 bags of litter, removing unsightly graffiti, and restoring swathes of habitat. The public can get involved by signing up to participate in one of the organised clean up events at www.pgcapitalcleanup.com

P&G are official sponsors of the London Olympic Games.

Are you looking for a new job in fast moving consumer goods? Click here to see our latest FMCG jobs?

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , ,

Research says that men who drink 7 cups of tea a day are 50% more likely to develop prostate cancer

The Telegraph reported that a research study at Glasgow University  has said that men who drink a lot of tea a day are 50 per cent more likely to develop prostate cancer

Glasgow University found that people who drink more than seven cups of tea are at a much higher risk of getting the disease than those who consume three cups or fewer.

The warning comes after scientists at the University of Glasgow tracked the health of more than 6,000 men for four decades.  The participients were aged between  21 and 75 were asked to complete a questionnaire about their usual consumption of tea, coffee and alcohol as well as their smoking habits and general health, and had to attend a screening examination.

Dr Kate Holmes, head of research at The Prostate Cancer Charity, said: ‘Whilst it does appear that those who drank seven or more cups of tea each day had an increased risk of developing prostate cancer, this did not take into consideration family history or any other dietary elements other than tea, coffee and alcohol intake……It is therefore unclear as to whether there were other factors in play which may have had a greater impact on risk.

Are you looking for a new scientist job? Click here to search our scientist jobs online now

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , , ,

Merck sign $303 million biotherapeutics deal

PharmaTimes has reported that Merck & Co has entered into a possible $303 million USD collaboration with Ambrx to develop ‘smart bomb’ antibodies.

Merck hope to develop biologic drug conjugates using Ambrx’s “site-specific protein medicinal chemistry technology”

Merck is paying an upfront fee of $15 million and is eligible to receive milestones totalling up to $288 million. Ambrx will also receive royalties.

Richard Murray, head of biologics and vaccines research at Merck said that this collaboration will allow us to combine Ambrx’s expertise in site-specific protein conjugation chemistry with Merck’s expanding antibody capabilities and extensive small molecule resources.

Click here to see our latest scientifc jobs

Follow us on Twitter @CKScienceJobs to receive more industry news and CK jobs of the week updates

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , ,

UK manufacturing to get £6.5m through R&D projects

The Engineer has reported that UK manufacturing is to receive a £6.5m innovation boost through 16 new research and development projects to develop new production technologies

The Engineering and Physical Sciences Research Council and the Technology Strategy Board are to provide grant funding to support the development of new technologies that have the potential to underpin new production processes in a wide range of industrial applications and market sectors. The research will focus on novel manufacturing processes and techniques, resource efficiency and greater environmental sustainability through the efficient disposal or recycling of asset.

Companies including Airbus Operations, GKN Aerospace and Unilever will lead the projects, which will lead to technologies such as innovative car-painting methods, autonomous intelligent machining, the online control of welding processes using ultrasonic test techniques, and sustainable and resource-efficient titanium cutting.

Are you looking for a new job in engineering? Click here to see our latest engineering roles!

Posted in Industry News, NewsTagged in , , , , , , , , , , , ,

UK offshore wind could create 215,000 Jobs

The Bloomsberg Business week reported that the U.K. offshore wind industry could create 215,000 jobs and boost exports by up to 22.5 billion pounds by 2030.

The Centre for Economics and Business Research said in a report commissioned by Irish wind developer Mainstream Renewable Power Ltd that the Development of the industry may “see an annual 1 percent uplift” in gross domestic product.  The estimates are based on the installation of 49 gigawatts of offshore wind by 2030 resulting in 97,000 jobs created by 2020, assuming offshore wind generation reaches 17 gigawatts.

Mainstream Renewable’s Chief Executive Officer Eddie O’Connor said “By creating a new industry, offshore wind will create jobs, assist in balancing the trade deficit and boost GDP at a time of economic uncertainty,”

Would you like a new job in the environmental industry? Click here to see our latest environmental jobs

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , ,

Scientists have grown human bone from stem cells

The Telegraph has reported that scientists have succeeded in growing human bone from stem cells in a laboratory, which they claim may eventually pave the way for patients to have broken bones repaired or replaced with new ones grown outside the body.

The researchers started with stem cells taken from fat tissue. It took around a month to grow them into sections of fully-formed living human bone up to a couple of inches long.  The technology, which has been developed along with researchers at the Technion Institute of Research in Israel, uses three dimensional scans of the damaged bone to build a gel-like scaffold that matches the shape.

The first trial in patients is on course to be conducted later this year, by an Israeli biotechnology company Bonus BioGroup that has been working with academics on the technology.

Professor Avinoam Kadouri, head of the scientific advisory board for Bonus BioGroup, said: “There is a need for artificial bones for injuries and in operations…..We use three dimensional structures to fabricate the bone in the right shape and geometry. We can grow these bones outside the body and then transplant it to the patient at the right time”

Are you looking for a new job in science? Click here to see our latest jobs

Follow us on Twitter @CKScienceJobs to receive more industry news and CK jobs of the week updates

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , ,

Norwegian oil services firm Aker Solutions to create 1300 new jobs in London

The Telegraph reported that Norwegian oil services firm Aker Solutions says it aims to build up a 1 700-strong London engineering hub thereby creating 1 300 new jobs by 2015, as growth in global oil and gas markets drives demand for the company’s technologies and services.

Aker Solutions provides oilfield products, systems and services for customers in the oil and gas industry, and is listed on the Oslo stock exchange. The company, which employs more than 3000 people in the UK, opened a new office in Chiswick Park, West London, last year.

UK Prime Minister David Cameron said: “Aker Solution’s decision to create 1300 new jobs at a new engineering hub in Chiswick is great news for the local economy and it is a vote of confidence in the skill, expertise and professionalism of our engineering sector.”

Are you looking for a new job in the oil and gas industry? Click here to see our latest oil and gas jobs

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , , , , ,